11 topics, 3 replies

Results

• ICMJE update: phase I clinical trial registration is mandatory

  Posted by:

  Tali Swann-Sternberg

  Tags:

  • international committee of medical journal editors
  • clinical trials
  • phase i clinical trials
  • trial registration
  • clinical research
  • icmje
  • clinical trials

• Personalized Medicine: Elusive Dream or Imminent Reality?

  Posted by:

  Tali Swann-Sternberg

  Tags:

  • personalized medicine
  • clinical medicine
  • pharmacogenomics
  • pharmacogenetics
  • pharmacology
  • therapeutics

• Could this be a possible treatment for HIV/AIDS?

  Posted by:

  Douglas Pereira

  Tags:

  • gag gene
  • hiv
  • aids
  • antisense
  • antiviral

• Pharmacoecology Discussion

  Posted by:

  Katie Young

  Tags:

  • cpt
  • pharmacology
  • therapeutics
  • pharmacogenetics
  • pkpd
  • environment
  • cyp450
  • ephedrine
  • fda
  • pharmacoecology
  • drugs
  • pharmacokinetics
  • pharmacodynamics

  1 reply

  last reply:
  10 March 2008 by Ken-ichi Fujita

• Emergency Contraception: Effectiveness, Expectations, and Accessibility

  Posted by:

  Katie Young

  Tags:

  • pregnancy
  • levonorgestrel
  • womens health
  • emergency contraception

  1 reply

  last reply:
  21 January 2008 by User removed

• Breast Cancer Prevention and Treatment: Multidisciplinary Approaches

  Posted by:

  Katie Young

  Tags:

  • womens health
  • breast cancer
  • tamoxifen

• Osteoporosis: Cathepsin K inhibitors, Alternative Treatments, and Successful Studies

  Posted by:

  Katie Young

  Tags:

  • womens health
  • cathepsin k inhibitors
  • osteoporosis

• Synergism or Additivity.

  Posted by:

  D Baunbaek

  Tags:

  • drug combination
  • synergism
  • additivity

  2 replies

  last reply:
  29 November 2007 by Katie Young

• Medical marijuana

  Posted by:

  Tali Swann-Sternberg

  Tags:

  • medical marijuana
  • smokeless marijuana
  • marijuana
  • cannabis
  • thc
  • legislation

• Is model-based drug development (MBDD) the solution to the high cost and low productivity that now plagues this field?

  Posted by:

  Tali Swann-Sternberg

  Tags:

  • modelbased drug development
  • mbdd
  • drug development
  • critical path
  • clinical trials

Results